ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Hydroxychloroquine Questions"
Episode Synopsis
Hydroxychloroquine has evolved from a sleepy anti-malaria drug into a partisan litmus test over the future of COVID-19 treatment. Dan and Axios healthcare reporter Bob Herman dig into what we know about the drug, what we still don't, and why both matter.
PLUS: New money for small businesses and a way to help New York medical workers
PLUS: New money for small businesses and a way to help New York medical workers
More episodes of the podcast Axios Re:Cap
2021's challenges for journalism
22/12/2021
The year psychedelics went mainstream
21/12/2021
Biden's big immigration challenges
20/12/2021
Reflecting on our second year of COVID
17/12/2021
A big year for blockchain
16/12/2021
The shortage economy of 2021
16/12/2021
The great space race of 2021
15/12/2021
Covering Washington in 2021
14/12/2021
In God we trust